Clinical Trials on Localized Breast Carcinoma in Japan
Total 979 results
-
Okayama UniversityMerck Sharp & Dohme LLCRecruitingBreast Cancer | Breast Neoplasms | Triple Negative Breast Cancer | Triple Negative Breast Neoplasms | BRCA1 Mutation | BRCA2 Mutation | BRCA Mutation | BRCA-Associated Breast CarcinomaJapan
-
Eli Lilly and CompanyTerminatedHepatocellular Carcinoma | Solid Tumor | Gastric Adenocarcinoma | Leiomyosarcoma | Head and Neck Squamous Cell Carcinoma | Cervical Carcinoma | Triple-negative Breast Cancer | Undifferentiated Pleomorphic Sarcoma | High Grade Serous Ovarian CarcinomaUnited States, Japan
-
TakedaCompletedPremenopausal Breast CancerJapan
-
Kyoto UniversityWithdrawnLocalized Resectable Adult Primary Liver Cancer | Stage III Childhood Liver CancerJapan
-
AgendiaOsaka General Medical CenterCompleted
-
PfizerActive, not recruitingBreast CancerJapan, Korea, Republic of, Taiwan
-
Japanese Foundation for Cancer ResearchChugai PharmaceuticalActive, not recruiting
-
Kyoto Breast Cancer Research NetworkCompleted
-
Osaka Medical CollegeCompletedBreast Cancer | Effects of Chemotherapy | HER-2 Positive Breast CancerJapan
-
Comprehensive Support Project for Oncology ResearchCompleted
-
AstraZenecaCompletedStomach Neoplasms | Small Cell Lung Carcinoma | Ovarian Neoplasms | Fallopian Tube Neoplasms | Peritoneal Neoplasms | Triple Negative Breast Neoplasms | Esophageal Squamous Cell Carcinoma | Carcinoma, Pancreatic Ductal | Carcinoma, Squamous Cell of Head and Neck | Esophagogastric Junction NeoplasmsKorea, Republic of, Japan
-
Tokyo Medical UniversityTokyo University; Saint Luca International HospitalCompleted
-
Kyoto Prefectural University of MedicineActive, not recruiting
-
Kyoto Breast Cancer Research NetworkTerminated
-
Tokyo Medical and Dental UniversityRecruitingBreast Cancer | Metastatic Breast Cancer | OligometastasisJapan
-
Nippon Kayaku Co., Ltd.CompletedBreast Cancer Nos Metastatic RecurrentJapan
-
GlaxoSmithKlineCompleted
-
AstraZenecaCompletedNeoplasms | Breast Cancer | Metastatic CancerJapan
-
Osaka Medical CollegeTerminatedBreast Cancer | HER-2 Positive Breast Cancer | Estrogen Receptor Negative NeoplasmJapan
-
Tokyo UniversityHuman Genome Center, Institute of Medical Science, University of TokyoTerminated
-
Eli Lilly and CompanyCompletedBreast Cancer | Metastatic Breast CancerJapan
-
National Cancer Center, JapanH.U. Group Research Institute G.K.RecruitingHER2-positive Breast CancerJapan
-
Tokyo UniversityHuman Genome Center, Institute of Medical Science, University of TokyoTerminated
-
Eisai Co., Ltd.CompletedBreast Cancer | HER2-negative Breast CancerJapan
-
CelltrionNippon Kayaku Co., Ltd.CompletedHER2-positive Carcinoma of BreastItaly, South Africa, Mexico, Japan, Taiwan, Russian Federation, Philippines, Hungary, Romania, Spain, Bosnia and Herzegovina, India, Peru, Ukraine, Latvia, Argentina, Georgia, Belarus, Chile, France, Poland, Portugal
-
AstraZenecaActive, not recruitingER+ HER2- Advanced Breast CancerJapan
-
Chugai PharmaceuticalCompleted
-
Niigata University Medical & Dental HospitalMerck Sharp & Dohme LLCRecruitingOvarian Squamous Cell CarcinomaJapan
-
National Cancer Center, JapanMerck Sharp & Dohme LLCRecruitingUntreated Advanced or Recurrent Thymic CarcinomasJapan
-
Japan Breast Cancer Research GroupChugai PharmaceuticalCompletedMetastatic Breast CancerJapan
-
Bristol-Myers SquibbOno Pharmaceutical Co. LtdNot yet recruitingMuscle-invasive Urothelial CarcinomaJapan
-
AstraZenecaCompleted
-
Comprehensive Support Project for Oncology ResearchNovartis PharmaceuticalsCompleted
-
National Cancer Center, JapanOno Pharmaceutical Co. Ltd; Fiverings Co., Ltd.Active, not recruitingLocally Advanced Esophageal Squamous Cell CarcinomaJapan
-
AstraZenecaCompleted
-
Zeria PharmaceuticalCompletedAdvanced Hepatocellular CarcinomaJapan
-
Daiichi Sankyo Co., Ltd.AstraZeneca; Daiichi Sankyo, Inc.RecruitingTriple Negative Breast Cancer | Non-small Cell Lung Cancer | Hormone Receptor Positive Breast CancerUnited States, Japan
-
GlaxoSmithKlineCompletedNeoplasms, BreastJapan
-
GlaxoSmithKlineCompleted
-
Taiho Pharmaceutical Co., Ltd.Completed
-
Eisai Co., Ltd.Completed
-
Bristol-Myers SquibbOno Pharmaceutical Co. LtdActive, not recruitingAdvanced or Metastatic Renal Cell CarcinomaJapan
-
Eisai Co., Ltd.Active, not recruiting
-
Translational Research Center for Medical Innovation...Department of breast and endocrine surgery graduate school of Medicine Osaka...Terminated
-
Translational Research Center for Medical Innovation...Okayama University; Japanese Gynecologic Oncology Group (JGOG)RecruitingFallopian Tube Carcinoma | Peritoneal Carcinoma | Ovarian Carcinoma | BRCA1 and/or BRCA2 Variant CarriersJapan
-
National Cancer Institute (NCI)CompletedHER2-positive Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast CancerUnited States, Japan
-
Institut de Recherches Internationales ServierADIR, a Servier Group companyCompletedMetastatic Breast Cancer | Metastatic Triple Negative Breast CancerJapan, Belgium, France, Netherlands
-
Fukushima Medical UniversityHuman Genome Center, Institute of Medical Science, University of TokyoUnknownHepatocellular CarcinomaJapan
-
Comprehensive Support Project for Oncology ResearchActive, not recruitingStomach Cancer | Breast Cancer | Colorectal Cancer | Ovarian Cancer | Lung Cancer | Squamous Cell Carcinoma of the Head and Neck | Endometrial Cancer | Liver CancerJapan